Characterising differential antibody response is integral to future SARS-CoV-2 serostudies
J Infect
.
2020 Dec;81(6):e28-e30.
doi: 10.1016/j.jinf.2020.07.029.
Epub 2020 Jul 31.
Authors
Scott John Charles Pallett
1
,
Rachael Jones
2
,
Mitchell Anthony Pallett
2
,
Michael Rayment
2
,
Nabeela Mughal
2
,
Gary William Davies
2
,
Luke Stephen Prockter Moore
2
Affiliations
1
Royal Centre for Defence Medicine, Birmingham, United Kingdom. Electronic address: scott.pallett@nhs.net.
2
Royal Centre for Defence Medicine, Birmingham, United Kingdom.
PMID:
32739486
PMCID:
PMC7392850
DOI:
10.1016/j.jinf.2020.07.029
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Viral
Antibody Formation
COVID-19*
Humans
Kinetics
SARS-CoV-2*
Substances
Antibodies, Viral
Grants and funding
WT_/Wellcome Trust/United Kingdom